Effects of resveratrol on oxidative modification of human low density lipoprotein

Chinese Medical Journal

Volumn 113, Issue 2, 2000, Pages 99-102

  Zou, Jiangang ^a   Huang, Yuanzhu ^a   Chen, Qi ^a   Wei, Enhui ^a   Cao, Kejiang ^a   Wu, Joseph ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Antioxidant; Degradation; Low density lipoprotein; Macrophage; Oxidation; Resveratrol

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ANTIOXIDANT; COPPER ION; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; RESVERATROL; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

ANIMALS; ANTIOXIDANTS; AZO COMPOUNDS; CELLS, CULTURED; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MALONDIALDEHYDE; MICE; OXIDATION-REDUCTION; STILBENES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 0343091521     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit: an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A 1987;84:5928-5931.
2. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 1993;328:1444-1449.
3. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
4. Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-415.
5. Renaud S, de Lorgeril M. Wine, alcohol, platelet and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
6. Frankel EN, Waterhouse AL, Kinselia JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341:1103-1104.
7. Frankel EN, Kanner J, German JB, et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.
8. Chen Q, Esterbauer H, Jurgens G. Studies on epitopes on low density lipoprotein modified by 4-hydroxynonenal: biochemical characterization and determination. Biochem J 1992;288:249-254.
9. McFarlane AS. Efficient trace-labeling of proteins with iodine. Nature 1958;182:53-54.
10. Lougheed M, Steinbrecher UP. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent its extent of oxidation. J Biol Chem 1996;271:11798-11805.
11. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci U S A 1991;88:1646-1650.
12. Steinberg D. Lipoproteins and atherosclerosis: a look back and a look ahead. Atherosclerosis 1983;3:283-301.
13. Goldstein JL, Ho YK, Basu SK, et al. Binding sites on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-337.
14. Steinbrecher UP, Parthasarathy S, Leake DS, et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Nad Acad Sci U S A 1984;81:3883-3887.
15. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997;30:91-113.
16. Arichi H, Kimura Y, Okuda H, et al. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb, et Zucc. on lipid metabolism. Chem Pharm Bull 1982;30:1766-1770.